(Q50692146)
Statements
Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32) (English)
Werwitzke S
Trick D
Sondermann P
Kamino K
Schlegelberger B
Kniesch K
Jacob U
Schmidt RE
scientific article published on 8 June 2007